Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Life Sciences - March, 2006
56 articles
- Authorized Generics Under Scrutiny By The FTC
- Authorized Generics: Antitrust Issues And The Hatch-Waxman Act
- Ailing Healthcare Company Gets Shot In The Arm
- Drug Industry Faces Vast Antitrust Probe
- In Paxil Fraud Scheme, Glaxo Pays The Price
- Medtronic Suffers Fresh Defeat In Stent Dispute
- Despite Patent Attack, Schering Will Bring Yaz To U.S.
- Judge Refuses Boston Scientific Bid To Toss Jury Verdict
- Reed Smith's IP Group: A True Blend
- Class Action Suit Filed Over Stock Price Tampering
- E.U. Expands Antitrust Review Of Guidant Deal
- Curative Health Files Chapter 11 With $255M In Debts
- Brussels Snapshot: Shearman & Sterling
- Plavix Deal Triggers Antitrust Lawsuit
- In Setback For Masimo, Judge Tosses $420M Award
- Boston Scientific Merger Delayed Over EC Concerns
- Arnold & Porter Tops Antitrust Litigation Survey
- Aventis Presses On With Allegra Crusade
- J&J Unit Loses Out To Medtronic In Stent Case
- Trademark Specialist Fross Zelnick Flies Solo
- Apotex Surrenders In Plavix Patent Saga
- Ivax, Forest Square Off Over Antidepressant Drug
- Supreme Court Hears Much-Watched LabCorp Case
- Drug Stores Allege Ovcon Antitrust Conspiracy
- In Levaquin Patent Battle, Daiichi Scores Again
- In Blow To EchoStar, Judge Advances TiVo Case
- St. Jude Caught In SEC's Oil-For-Food Net
- Brussels Snapshot: Skadden Arps
- J&J Subsidiary Scores Another Victory In Stent Case
- USG Seeks To Acquire Paper Mill for $18M
- Novartis Takes Aim At Watson Over Lotrel
- FDA Forced To Review Cholesterol Drug Exclusivity
- Abbott Bids To Toss Antitrust Charges Over TriCor
- BASF, Daiichi Vitamin Cartel Fines Slashed By E.U. Court
- Apotex Launches Pre-Emptive Strike Against Par
- J&J On Warpath Over Schizophrenia Drug
- Solvay, Akzo Nobel Fined $72M For Chemical Cartels
- Boston Scientific Curiously Withdraws Then Refiles
- Novogen Sues Chattem Over Preventative Health Methods
- Latham & Watkins Scores New Partner
- Allergan, Alcon Settle Patent Feud Over Eye Drops
- Botched Deal Follows AAIPharma's Solvency
- AstraZeneca Starts Patent Squabble With IVAX
- Pfizer Sues Philippines Over Generic Norvasc
- Bill Would Cut Use Of 30-Month Stay In Drug Suits
- Roche Wins First Indian Product Patent
- Medtronic Pins Infringement Charges on Boston Scientific
- Federal Circuit Sends Stent Case To Germany
- Conferences Highlight Foley & Lardner's IP Expertise
- E.U. Probes Boston Scientific, Abbott Over Guidant Bids
- Sanofi-Aventis Slaps Ranbaxy With Allegra Patent Suit
- Alza Hit With Class Action Lawsuit Over Ditropan XL
- Metrologic Ordered To Pay $13M Arbitration Award
- MedImmune Case: Implications For Licensing Agreements
- ABB's Asbestos-Related Reorganization Approved
- AstraZeneca Hit Again With Antitrust Charges